
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.370 | 1.650 | 0.280 |
Shares | 98.620 | 98.620 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.221 | 16.953 |
Price to Book | 1.587 | 2.136 |
Price to Sales | 1.647 | 1.747 |
Price to Cash Flow | 8.494 | 11.438 |
Dividend Yield | 4.698 | 2.988 |
5 Years Earnings Growth | 4.866 | 7.116 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 42.510 | 20.838 |
Industrials | 39.480 | 40.282 |
Healthcare | 8.670 | 10.267 |
Technology | 3.850 | 8.189 |
Consumer Defensive | 3.610 | 4.723 |
Basic Materials | 1.880 | 4.728 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Investor B | SE0015811963 | 9.57 | 291.0 | -0.41% | |
Volvo B | SE0000115446 | 8.95 | 284.20 | -1.15% | |
Swedbank A | SE0000242455 | 8.57 | 256.50 | -0.23% | |
Nordea Bank | FI4000297767 | 6.87 | 12.610 | +0.08% | |
Traton | DE000TRAT0N7 | 5.29 | 30.08 | -4.87% | |
Danske Bank | DK0010274414 | 4.85 | 259.8 | -0.04% | |
Sandvik AB | SE0000667891 | 4.59 | 241.70 | -1.15% | |
SKF B | SE0000108227 | 4.53 | 234.1 | -1.10% | |
SEB A | SE0000148884 | 4.41 | 170.30 | -0.21% | |
AstraZeneca | GB0009895292 | 4.29 | 10,790.0 | -0.11% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Sverige Indexfond | 47.02B | 0.78 | 11.62 | 9.04 | ||
SEB Sverige Indexfond utd | 47.02B | 0.78 | 11.62 | 9.04 | ||
SEB Sverige Indexfond Institutional | 47.02B | 0.72 | 6.90 | 8.43 | ||
SEB Varldenfond | 39.1B | -2.55 | 9.76 | 5.88 | ||
SEB Sverige Smabol C R utd | 26.13B | 2.15 | 13.22 | 16.15 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review